{{drugbox
| IUPAC_name = 7-[(4''Z'')-3-(aminomethyl)- 4-methoxyimino-pyrrolidin-1-yl]- 1-cyclopropyl-6-fluoro-4-oxo- 1,8-naphthyridine-3-carboxylic acid
| image = Gemifloxacin.svg
| CAS_number = 175463-14-6
| ATC_prefix = J01
| ATC_suffix = MA15
| ATC_supplemental = 
| PubChem = 5464436
| DrugBank = APRD00053
| C = 18 | H = 20 | F = 1 | N = 5 | O = 4
| molecular_weight = 389.381 g/mol
| bioavailability = 
| protein_bound = 60-70%
| metabolism = 
| elimination_half-life = 
| pregnancy_category = 
| legal_status = 
| routes_of_administration = 
}}
'''Gemifloxacin mesylate''' (trade name '''Factive®''', [[Oscient Pharmaceuticals]]) is an oral broad-spectrum [[quinolone]] [[antibacterial]] agent used in the treatment of acute bacterial exacerbation of chronic [[bronchitis]] and mild-to-moderate [[pneumonia]].

{{QuinoloneAntiBiotics}}

[[Category:Fluoroquinolone antibiotics]]


{{antibiotic-stub}}

[[th:เจมิฟลอกซาซิน]]